Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.5 (
thrombin
)
33,306
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
BACKGROUND AND PURPOSE The Na(+) /Ca(2+) exchanger is a bi-directional transporter that plays an important role in maintaining the concentration of cytosolic Ca(2+) ([Ca(2+) ](i) ) of quiescent platelets and increasing it during activation with some, but not all, agonists. There are two classes of Na(+) /Ca(2+) exchangers: K(+) -independent Na(+) /Ca(2+) exchanger (NCX) and K(+) -dependent Na(+) /Ca(2+) exchanger (NCKX). Platelets have previously been shown to express NCKX1. However, initial studies from our laboratory suggest that NCX may also play a role in platelet activation. The objective of this study was to determine if the human platelet expresses functional NCXs. EXPERIMENTAL APPROACH RT-PCR, DNA sequencing and Western blot analysis were utilized to characterize the human platelet Na(+) /Ca(2+) exchangers. Their function during quiescence and collagen-induced activation was determined by measuring [Ca(2+) ](i) with calcium-green/fura-red in response to: changes in the Na(+) and K(+) gradient, NCX pharmacological inhibitors (CBDMB, KB-R7943 and SEA0400) and antibodies specific to extracellular epitopes of the exchangers. KEY RESULTS Human platelets express NCX1.3,
NCX3
.2 and
NCX3
.4. The NCXs operate in the Ca(2+) efflux mode in resting platelets and also during their activation with
thrombin
but not collagen. Collagen-induced increase in [Ca(2+) ](i) was reduced with the pharmacological inhibitors of NCX (CBDMB, KB-R7943 or SEA0400), anti-NCX1 and anti-
NCX3
. In contrast, anti-NCKX1 enhanced the collagen-induced increase in [Ca(2+) ](i) . CONCLUSIONS AND IMPLICATIONS Human platelets express K(+) -independent Na(+) /Ca(2+) exchangers NCX1.3,
NCX3
.2 and
NCX3
.4. During collagen activation, NCX1 and
NCX3
transiently reverse to promote Ca(2+) influx, whereas NCKX1 continues to operate in the Ca(2+) efflux mode to reduce [Ca(2+) ](i) .
...
PMID:Molecular and functional characterization of the human platelet Na(+) /Ca(2+) exchangers. 2179 May 37
Human platelets use a rise in cytosolic Ca
2+
concentration to activate all stages of thrombus formation, however, how they are able to decode cytosolic Ca
2+
signals to trigger each of these independently is unknown. Other cells create local Ca
2+
signals to activate Ca
2+
-sensitive effectors specifically localised to these subcellular regions. However, no previous study has demonstrated that agonist-stimulated human platelets can generate a local cytosolic Ca
2+
signal. Platelets possess a structure called the membrane complex (MC) where the main intracellular calcium store, the dense tubular system (DTS), is coupled tightly to an invaginated portion of the plasma membrane called the open canalicular system (OCS). Here we hypothesised that human platelets use a Ca
2+
nanodomain created within the MC to control the earliest phases of platelet activation. Dimethyl-BAPTA-loaded human platelets were stimulated with
thrombin
in the absence of extracellular Ca
2+
to isolate a cytosolic Ca
2+
nanodomain created by Ca
2+
release from the DTS. In the absence of any detectable rise in global cytosolic Ca
2+
concentration,
thrombin
stimulation triggered Na
+
/Ca
2+
exchanger (NCX)-dependent Ca
2+
removal into the extracellular space, as well as Ca
2+
-dependent shape change in the absence of platelet aggregation. The NCX-mediated Ca
2+
removal was dependent on the normal localisation of the DTS, and immunofluorescent staining of
NCX3
demonstrated its localisation to the OCS, consistent with this Ca
2+
nanodomain being formed within the MC. These results demonstrated that human platelets possess a functional Ca
2+
nanodomain contained within the MC that can control shape change independently of platelet aggregation.
...
PMID:Human platelets use a cytosolic Ca
2+
nanodomain to activate Ca
2+
-dependent shape change independently of platelet aggregation. 3262 99